Fort Washington Investment Advisors Inc. OH Grows Position in Option Care Health, Inc. $OPCH

Fort Washington Investment Advisors Inc. OH lifted its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 2.9% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,479,728 shares of the company’s stock after purchasing an additional 42,317 shares during the quarter. Fort Washington Investment Advisors Inc. OH’s holdings in Option Care Health were worth $39,834,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Durable Capital Partners LP lifted its position in Option Care Health by 134.2% during the second quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock valued at $267,557,000 after buying an additional 4,720,988 shares during the period. Southpoint Capital Advisors LP purchased a new stake in shares of Option Care Health in the 4th quarter worth about $95,580,000. Norges Bank purchased a new stake in shares of Option Care Health in the 4th quarter worth about $61,787,000. Alyeska Investment Group L.P. bought a new position in shares of Option Care Health in the 4th quarter worth about $38,559,000. Finally, Freestone Grove Partners LP bought a new position in shares of Option Care Health in the 4th quarter worth about $29,181,000. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Price Performance

OPCH opened at $21.82 on Friday. The firm has a market cap of $3.43 billion, a PE ratio of 16.91, a P/E/G ratio of 1.21 and a beta of 0.67. The stock has a 50-day moving average price of $22.38 and a 200-day moving average price of $28.65. Option Care Health, Inc. has a 1 year low of $18.01 and a 1 year high of $36.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings data on Thursday, April 30th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.37 by $0.03. The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.39 billion. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. Option Care Health’s revenue for the quarter was up 1.3% on a year-over-year basis. During the same period in the prior year, the firm posted $0.40 EPS. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Sell-side analysts predict that Option Care Health, Inc. will post 1.64 earnings per share for the current fiscal year.

Insider Transactions at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 36,610 shares of Option Care Health stock in a transaction that occurred on Monday, May 4th. The stock was bought at an average price of $21.41 per share, with a total value of $783,820.10. Following the completion of the transaction, the director directly owned 450,000 shares of the company’s stock, valued at approximately $9,634,500. The trade was a 8.86% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO John Charles Rademacher acquired 12,500 shares of the firm’s stock in a transaction that occurred on Monday, May 4th. The stock was purchased at an average price of $21.18 per share, with a total value of $264,750.00. Following the completion of the acquisition, the chief executive officer owned 695,152 shares in the company, valued at $14,723,319.36. The trade was a 1.83% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last 90 days, insiders have bought 73,264 shares of company stock worth $1,548,316. Corporate insiders own 1.70% of the company’s stock.

Analyst Ratings Changes

OPCH has been the topic of several research reports. Barrington Research dropped their price objective on shares of Option Care Health from $42.00 to $32.00 and set an “outperform” rating on the stock in a research note on Friday, May 1st. Wall Street Zen downgraded shares of Option Care Health from a “buy” rating to a “hold” rating in a research note on Saturday, February 28th. Weiss Ratings lowered shares of Option Care Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. Truist Financial set a $30.00 price target on Option Care Health in a research report on Friday, May 1st. Finally, TD Cowen cut their price target on Option Care Health from $37.00 to $23.00 and set a “hold” rating on the stock in a research note on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $30.54.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.